Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07376135Not ApplicableNot Yet Recruiting

LETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment.

Role: collaborator

NCT04204239Unknown

Validation Study SCOBES-AR

Role: collaborator

NCT02130102Completed

ModuLAAr - A Module Based and Scalable System for Silver-ager in Austria

Role: collaborator

NCT00916487Not ApplicableCompleted

Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption

Role: collaborator

All 4 trials loaded